Zimmer Biomet is making significant strides in the Ambulatory Surgery Center (ASC) market, reflecting the broader industry trend towards outpatient care. This strategic shift aims to enhance patient outcomes and reduce healthcare costs. Becker’s spoke with Nnamdi Njoku, president of sports medicine, surgery, upper extremities, and restorative therapies at Zimmer Biomet, to see what else the company intends to accomplish through its latest partnership. What innovative approaches is Zimmer Biomet implementing, and how will they shape the future of ASCs?
Keep Reading
Add A Comment